RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

In addition, we will likely see cuts in NIH funding in the new congress.

I've come to the conclusion that the NIH should play a VC role, funding microcaps to get drugs to late stage, and sharing the profits from successful drugs. There are conflict-of-interest issues that would need to be adressed, but the current system is inefficient: almost all of the basic research that NIH funds doesn't reach patients, because the commercialization mechanism is broken.